Nicotinell

Nicotine, the active ingredient in Nicotinell, is a nicotine replacement therapy presented as an unknown/unknown for oromucosal use. It helps adults who are dependent on tobacco by reducing withdrawal symptoms and cravings during smoking cessation attempts. It is intended for use by adult smokers who have decided to quit and can be part of a comprehensive cessation program that includes counseling.

GNH USA supplies Nicotinell as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Nicotinell, a nicotine replacement therapy, acts on the nicotinic acetylcholine receptors to aid smoking cessation.

- Smoking cessation: reduces nicotine withdrawal symptoms and cravings, supporting quit attempts. - Tobacco dependence: provides a controlled nicotine dose to facilitate gradual reduction of tobacco use. - Relapse prevention: helps maintain abstinence by managing occasional urges after quitting.

Nicotinell may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Mouth irritation - Throat irritation - Nausea - Headache

Serious or Rare Side Effects: - Allergic reaction (rash, swelling, breathing difficulty) - Chest pain or palpitations - Severe nausea or vomiting

When using Nicotinell, certain precautions should be observed to ensure safety and effectiveness.

- Cardiovascular assessment: evaluate history of heart disease before initiating therapy. - Medical supervision: use under guidance of a healthcare professional, especially for high‑risk patients. - Recent myocardial infarction: avoid use within the first two weeks after a heart attack. - Concomitant nicotine products: do not use other nicotine replacement or tobacco products simultaneously. - Pregnancy and breastfeeding: consult a physician before use, as safety data are limited. - Store at ambient temperature: keep below 25 °C in the original packaging, protected from moisture.

Nicotinell can interact with other medicines; awareness of major and moderate interactions helps prevent adverse outcomes.

Major Interactions (Avoid): - Cardiovascular drugs (e.g., nitroglycerin): nicotine may increase heart rate and blood pressure, risking ischemia. - Monoamine oxidase inhibitors (MAOIs): combined sympathomimetic effects may cause hypertensive crises.

Moderate Interactions (Monitor Closely): - CYP2A6 inhibitors (e.g., methoxsalen): may raise nicotine plasma levels, requiring monitoring. - Antidepressants (especially SSRIs): nicotine can alter their metabolism, affecting efficacy. - Antidiabetic agents (insulin or oral hypoglycemics): nicotine may affect glucose control, necessitating blood‑sugar monitoring.